|
Led by Dr.
Jeffrey Prichard,
the Geisinger Medical Laboratories (GML) Breast Pathology Subspecialty
Group includes Dr. Hongbing Deng, Dr. Haiyan
Liu, Dr. Steven
Meschter,
Dr. Hong Yin and Dr.
Xiahong (Mary) Zhang. They specialize in diseases of the breast,
both benign and malignant. They offer comprehensive diagnostic services,
including diagnosis of:
- Ductal carcinoma
- Fat necrosis
- Fibroadenomas
- Fibrocystic disease
- Lactating adenoma
- Galactorrhea
- Hyperplasia
- Intraductal papilloma
- Lobular carcinoma
- Lymph node metastasis
- Mammary duct ectasia
- Mastitis
- Microcalfications
- Nipple discharge
- Paget disease
- Sclerosing adenosis
Members of the team have published research and given presentations at national and international conferences.
-
Liu H, Shi J, Xu Y, Zhang K, Kaspar H, Lin F. Reevaluation of diagnostic value of p120 catenin in differentiating lobular carcinoma from low-grade ductal carcinoma of the breast. Poster. Annual CAP Meeteing, Washington, DC, October 2009.
-
Siegelmann-Danieli N, Khandwlwal V, Wood GC, Mainali R, Prichard JW, Murphy TJ, Evans JF, Yumen O, Bernath AM. Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. Clin Breast Cancer 7. 59-66, 2006.
-
Liu H, Lin F, Prichard JW. Sensitivity and Specificity of Immunohistochemical (IHC) detection of ER and PR in Breast Carcinoma on Cell Block Cytology by Quantitative Image Analysis (QIA). Abstract. Modern Pathol 19, 284, 2006.
|
|
